Elsevier

Il Farmaco

Volume 53, Issue 1, January 1998, Pages 58-61
Il Farmaco

Regular paper
Multifunctional derivatives of metronidazole

https://doi.org/10.1016/S0014-827X(97)00007-4Get rights and content

Abstract

The design and synthesis of a series of multifunctional metronidazole derivatives are described. The main series are multi-esters having two or more metronidazole groups linked together by aryl or alkyl systems. A second system is two nitro-2-methylimidazole groups joined by a dimethylene link. The third is polymeric 2-(2-methyl-5-nitroimidazol-1-yl)ethyl acrylate. The triester, metronidazole trimesate, is exceptionally active as an antibacterial compound, which appears to be associated with a rigid, three-point attachment.

References (18)

There are more references available in the full text version of this article.

Cited by (11)

  • Metronidazole within phosphatidylcholine lipid membranes: New insights to improve the design of imidazole derivatives

    2018, European Journal of Pharmaceutics and Biopharmaceutics
    Citation Excerpt :

    Our results show that substituents of the side chain of metronidazole are important for its interaction with phosphatidylcholine lipid membranes and, consequently, for the disturbance of the membrane. Several studies have been trying to develop new imidazole derivatives (e.g., [66–68]). Ultimately, the structure–toxicity relationship of metronidazole within phosphatidylcholine membranes can provide new insights for the modification and design of new imidazole derivatives with lower toxicity.

  • PEG-metronidazole conjugates: Synthesis, in vitro and in vivo properties

    2005, Farmaco
    Citation Excerpt :

    Sterile solutions for infusion of 100.0 ml of 5 mg/ml of MTZ solutions are available. Several ester prodrugs of MTZ were reported in an effort to enhance its water solubility for parental administration, chemical stability, and membrane permeability and to diminish the susceptibility to enzymatic degradation [6–10]. In our research, a prodrug approach based on PEG as carrier polymer was adopted to overcome the solubility problem that prevents an easy formulation of parental solution and to modify the pharmacokinetic of the drug.

  • 2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl 4-fluorobenzoate

    2012, Acta Crystallographica Section E: Structure Reports Online
View all citing articles on Scopus
View full text